UROV - Seeking Alpha Catalyst Watch

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. A holiday-shortened week is on tap with Thanksgiving on the calendar. Looking a bit further out, here is a quick look at some upcoming catalysts in the healthcare sector for the balance of the year before next week's events are laid out. BioXcel (BTAI): A data readout from Phase 1b/2 study of BXCL501 for acute treatment of agitation in geriatric dementia/Alzheimer's is expected in before the end of the year. Biogen (BIIB): The estimated study completion date of Phase 1 trial of BIIB100 is December 21. Cortexyme (CRTX): Interim analysis for the Phase 2/3 trial of atuzaginstat (COR388) in mild- to-moderate

For further details see:

Seeking Alpha Catalyst Watch